Factors influencing haemostasis and blood transfusion in cardiac surgery

To find out the risk factors influencing perioperative bleeding and use of blood products in cardiac surgery so that appropriate intervent.ions can be selected for blood conservation, risk factors were analysed in 343 cardiac surgical patients, retrospectively, by multiple regression technique. The results showed that the factors related to postoperative bleeding were male gender, Higgins score, cardiopulmonary bypass (CPB) time, operation procedures, intraopera tive blood loss and use of internal mammary artery (IMA) graft. Factors related to perioperative homologous blood transfusions were emergency surgery, preoperative haemoglobin level, Higgins score, intraoperative blood loss, operation time and operation procedures. The geometric mean of postoperative bleeding in the entire series was 1085 ml and the mean packed red cell, plasma and platelet transfusions were 3.29 ± 0.4, 1.96 ± 0.39 and 0.21 ± 0.05 units respectively. The incidence of homologous blood transfusion during the hospital stay was 58.9% for the entire series and 54.5% in the nonrevision patients. Emergency patients received significantly more blood transfusion (p = 0.0001). Perioperative blood loss and transfusions are still problems in cardiac surgery and certain patient groups in this study were identified as high risk; available blood conservation techniques, therefore, are recommended in these patients.

[1]  S. Khuri,et al.  Effects of Cardiopulmonary Bypass on Hemostasis , 1997 .

[2]  K. Taylor Perioperative approaches to coagulation defects. , 1993, The Annals of thoracic surgery.

[3]  L. Edmunds Blood‐Surface Interactions During Cardiopulmonary Bypass , 1993, Journal of cardiac surgery.

[4]  G. Beck,et al.  Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. , 1992, JAMA.

[5]  M. Halfman-Franey,et al.  Recognition and management of bleeding following cardiac surgery. , 1991, Critical care nursing clinics of North America.

[6]  A. Belboul,et al.  High-dose aprotinin (trasylol) in reducing bleeding and protecting lung function in potential bleeders undergoing cardiopulmonary bypass. , 1991, Chinese medical journal.

[7]  A. van Breda,et al.  Thrombolysis in Arterial Bypass Grafts , 1991, Seminars in thrombosis and hemostasis.

[8]  S. Khuri,et al.  Hematologic Changes During and Following Cardiopulmonary Bypass and Their Relationship to Non-Surgical Blood Loss. 1. Platelet Function and the Bleeding Time. , 1990 .

[9]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[10]  A. Bernstein,et al.  A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. , 1989, Circulation.

[11]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.

[12]  S. Lemeshow,et al.  Blood conservation for myocardial revascularization. Is it cost effective? , 1987, The Journal of thoracic and cardiovascular surgery.

[13]  M. Dechavanne,et al.  Significant Reduction in the Binding of a Monoclonal Antibody (LYP 18) Directed Against the IIb/IIIa Glycoprotein Complex to Platelets of Patients Having Undergone Extracorporeal Circulation , 1987, Thrombosis and Haemostasis.

[14]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.

[15]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[16]  E. Michelson,et al.  Early recognition of surgically correctable causes of excessive mediastinal bleeding after coronary artery bypass graft surgery. , 1980, American journal of surgery.

[17]  P. Biglioli,et al.  The effect of "high dose" aprotinin and other factors on bleeding and revisions for bleeding in adult coronary and valve operations: an analysis of 2190 patients during a five-year period (1987-1991). , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  W. van Oeveren,et al.  Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. , 1994, European Journal of Cardio-Thoracic Surgery.

[19]  D. Roberts,et al.  Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypass. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.

[20]  A. Michelson Pathomechanism of Defective Hemostasis During and After Extracorporeal Circulation: The Role of Platelets , 1991 .

[21]  D. Roberts,et al.  Association between bleeding and reduced red cell deformability following cardiopulmonary bypass. , 1988, Scandinavian journal of thoracic and cardiovascular surgery.